Skip to main content
SpringerLink
Log in

Alemtuzumab

Thyroid disorders, neutropenia and erythema multiforme: 6 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Vakrakou A, et al. Early onset autoimmune manifestations after alemtuzumab treatment for multiple sclerosis: A single-center cohort study. Multiple Sclerosis Journal 24 (Suppl.): 944 abstr. EP1291, No. 2, Oct 2018. Available from: URL: http://doi.org/10.1177/1352458518798592 [abstract] - Greece

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alemtuzumab. Reactions Weekly 1776, 33 (2019). https://doi.org/10.1007/s40278-019-70191-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-70191-1

Search

Navigation